Literature DB >> 25311405

Clinical and epidemiological characteristics in children with community-acquired mycoplasma pneumonia in Taiwan: A nationwide surveillance.

Yun-Ju Ma1, Shih-Min Wang2, Yu-Hao Cho1, Ching-Fen Shen3, Ching-Chuan Liu4, Hsin Chi5, Yi-Chuan Huang6, Li-Min Huang7, Yhu-Chering Huang8, Hsiao-Chuan Lin9, Yu-Huai Ho10, Jung-Jung Mu11.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) is the leading cause of hospitalization of children. Mycoplasma pneumoniae is one of the most common pathogens. The disease severity is diverse, and the diagnosis remains a challenge to clinical pediatricians. The aims of this study are to provide a nationwide surveillance of the epidemiology and clinical manifestations of community-acquired mycoplasma pneumonia (CAMP) in children in Taiwan.
METHODS: The medical records of children enrolled by the Taiwan Pediatric Infectious Disease Alliance (TPIDA) project during 2010-2011 were reviewed. Hospitalized children with segmental or lobar pneumonia were included. The demographic, clinical, laboratory and radiographic data were analyzed. Nasopharyngeal swabs, pleural effusion, and serum were collected for multiplex viral and bacterial polymerase chain reaction (PCR), mycoplasma immunoglobulin M (IgM), or paired immunoglobulin G (IgG) titer.
RESULTS: There were overall 127 children with CAMP. Among them, 16 (12.6%) children had PCR and IgM positivity, 74 (58.3%) children had a positive serologic study, 34 (27.8%) children had positive PCR detection, and three (2.4%) children had paired IgG above a four-fold increase. Enrolled patients were divided into two groups before and after the age of 5 years. Children younger than 5 years or younger had a significantly longer hospitalization, higher intensive care unit (ICU) admission rates, and more complications. They were more frequent to receive oxygen supplementation and even surgical intervention. The white blood cell counts and C-reactive protein levels were higher in children 5 years old or younger.
CONCLUSION: Mycoplasma pneumoniae is an important etiology of CAP in children 5 years or younger. They had a longer length of hospitalization, higher inflammatory responses, and more complications, compared to children older than 5 years.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Children; Community-acquired pneumonia; Mycoplasma pneumoniae

Mesh:

Substances:

Year:  2014        PMID: 25311405     DOI: 10.1016/j.jmii.2014.08.003

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  20 in total

1.  Recent Developments in Pediatric Community-Acquired Pneumonia.

Authors:  Russell J McCulloh; Karisma Patel
Journal:  Curr Infect Dis Rep       Date:  2016-05       Impact factor: 3.725

2.  Role of Serum Mycoplasma pneumoniae IgA, IgM, and IgG in the Diagnosis of Mycoplasma pneumoniae-Related Pneumonia in School-Age Children and Adolescents.

Authors:  Wei-Ju Lee; Eng-Yen Huang; Chih-Min Tsai; Kuang-Che Kuo; Yi-Chuan Huang; Kai-Sheng Hsieh; Chen-Kuang Niu; Hong-Ren Yu
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

3.  Analysis of mycoplasma pneumoniae infection among children with respiratory tract infections in hospital in Chengdu from 2014 to 2020.

Authors:  Lei Zhang; Meimei Lai; Tao Ai; Huiling Liao; Yijie Huang; Ying Zhang; Yanru Liu; Li Wang; Jie Hu
Journal:  Transl Pediatr       Date:  2021-04

4.  Value of serum Mycoplasma pneumoniae immunoglobulin in the diagnosis of mycoplasma-related pneumonia in newborns.

Authors:  Yan Dong; Wei Lv; Zhen Lin
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

5.  Trends in Pediatric Complicated Pneumonia in an Ontario Local Health Integration Network.

Authors:  Tahereh Haji; Adam Byrne; Tom Kovesi
Journal:  Children (Basel)       Date:  2018-03-03

6.  Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia.

Authors:  Yeon Jin Cho; Mi Seon Han; Woo Sun Kim; Eun Hwa Choi; Young Hun Choi; Ki Wook Yun; SeungHyun Lee; Jung-Eun Cheon; In-One Kim; Hoan Jong Lee
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

7.  Increased risk of ankylosing spondylitis after Mycoplasma pneumonia: A Nationwide population-based study.

Authors:  Kuo-An Chu; Weishan Chen; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

8.  The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak.

Authors:  Andrew Po-Liang Chen; Chien Chuang; Ying-Chi Huang; Ping-Feng Wu; Shiang-Fen Huang; Nai-Cheng Cheng; Yi-Tsung Lin; Su-Jung Chen; Ling-Ju Huang; Chia-Lin Lee; Hsin-Pai Chen; Yu-Jiun Chan; Fu-Der Wang
Journal:  J Microbiol Immunol Infect       Date:  2021-06-22       Impact factor: 4.399

9.  The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan.

Authors:  Ching-Shu Tsai; Vincent Chin-Hung Chen; Yao-Hsu Yang; Tai-Hsin Hung; Mong-Liang Lu; Kuo-You Huang; Michael Gossop
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

10.  Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016.

Authors:  Jiuxin Qu; Chunxia Yang; Fang Bao; Shuyan Chen; Li Gu; Bin Cao
Journal:  BMC Infect Dis       Date:  2018-07-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.